LUNDBECK

LUN
Delayed Nasdaq Copenhagen - 10:59 2022-11-25 am EST
25.40 DKK -0.61%

Turn to zoom
Prev.25.40000000
Open25.69500000
High25.70000000
Low25.32000000
Volume32 835
Latest news
6d ago
11/09
11/09
11/09
Chart LUNDBECK
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance29,429,431,7
Spread/Res.-14%-14%-20%
Spread/Supp.1,4%6,0%6,7%
Support25,024,023,8
Financials
Sales 2022 18 057 M 2 524 M 2 524 M
Net income 2022 1 773 M 248 M 248 M
Net Debt 2022 1 981 M 277 M 277 M
P/E ratio 2022 -
Yield 2022 -
Capitalization 26 854 M 3 754 M 3 754 M
EV / Sales 2022 1,60x
EV / Sales 2023 1,29x
Nbr of Employees 5 452
Free-Float 100%
Company
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s...
Sector :
Other Pharmaceuticals
Calendar :
2022-12-05 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 25,40 DKK
Average target price 190,00 DKK
Spread / Average Target 648%